Skip to content
healthcare.dev

lisdexamfetamine dimesylate

NDC 47781-565, lisdexamfetamine dimesylate, capsule, from Alvogen Inc..

Product NDC
47781-565
Status
Listed
Labeler
Alvogen Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214547
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/47781-565 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE40 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
47781-565-0147781056501100 CAPSULE in 1 BOTTLE (47781-565-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7f2dd6ee-3363-c87c-9693-ed838942556c
  • NADAC price for package 47781056501

    GET /v1/drugs/nadac/47781056501

Use it

Look up 47781-565 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/47781-565 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 47781-565. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.